Miramar Labs Inc., a Menlo Park, Calif.-based developer of medical devices for aesthetic indications, has raised $20.34 million in Series B funding, according to a regulatory filing. Backers include Domain Associates, Morgenthaler Ventures and Split Rock Partners. The company does not have a website.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.